Walking Training Improves Thyroid and Cardiometabolic Markers in Postmenopausal Obesity
Moderate Intensity Intermittent Walking Training (MIWT) Improves Thyroid Function and Cardiometabolic Risk Factors in Obese Postmenopausal Women
1 other identifier
interventional
36
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the impact of a 10-week MIWT program on thyroid hormone levels and key cardiometabolic markers in obese postmenopausal women. The main question it aims to answer is: Does MIWT enhance thyroid function and reduce cardiometabolic risk factors in this population? Researchers will compare MIWT (designed to MIWT group) to non-training intervention (designed to control group) to see if the training program works to improve thyroid function and cardiometabolic risk factors. Participants in MIWT group will: perform a 10-week MIWT program, four sessions per week (5 repetitions of 6-min-walking-test (6MWT) at 60-80% of 6MWTdistance measured at baseline, interspersed by 6-min of active recovery between repetitions). Participants in control group will : not perform any physical training and maintain their usual daily activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 23, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 22, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 22, 2024
CompletedFirst Submitted
Initial submission to the registry
January 18, 2025
CompletedFirst Posted
Study publicly available on registry
January 27, 2025
CompletedJanuary 27, 2025
January 1, 2025
3 months
January 18, 2025
January 23, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Thyroid hormones
Serum thyroid hormone concentrations are measured from a blood sample (5 ml) obtained from a prominent superficial vein in the antecubital region.
At baseline and after ten weeks of MIWT.
Body composition
Body composition was assessed using an electronic scale (Tanita BC-533, Tokyo, Japan),
At baseline and after ten weeks of MIWT.
Lipid profile
Measured by blood samples (5ml) from a prominent superficial vein in the antecubital region.
At baseline and after ten weeks of MIWT.
Secondary Outcomes (4)
Systolic and diastolic blood pressure
At baseline and after ten weeks of MIWT.
Heart rate
At baseline and after ten weeks of MIWT
6 min walking test distance
At baseline and after ten weeks of MIWT
Perceived exertion rating
At baseline and after ten weeks of MIWT.
Study Arms (2)
MIWT group
EXPERIMENTALThe MIWT group received moderate intensity intermittent walking training four times per week for 10 weeks.
Control group
NO INTERVENTIONThe control group received no intervention for 10 weeks.
Interventions
The intensity of the training is 60 to 80% of 6MWTdistance.
Eligibility Criteria
You may qualify if:
- Body mass index≥ 30 kg.m-2.
- Age between 50 and 60.
- Amenorrhea for \>12 months.
- Stable eating habits.
You may not qualify if:
- Chronic diseases.
- Medical contraindications to physical activity.
- Hormone replacement therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wissal Abassilead
Study Sites (1)
High Institute of Sports and Physical Education of Kef
Boulifa, Kef Governorate, 7100, Tunisia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 18, 2025
First Posted
January 27, 2025
Study Start
September 23, 2024
Primary Completion
December 22, 2024
Study Completion
December 22, 2024
Last Updated
January 27, 2025
Record last verified: 2025-01
Data Sharing
- IPD Sharing
- Will not share
For confidentiality reasons, all data from this study are available upon request.